[(RS)-5-{4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione monohydrochloride]

ID: ALA3526905

Cas Number: 299176-11-7

PubChem CID: 9889104

Max Phase: Preclinical

Molecular Formula: C20H20ClN3O4S

Molecular Weight: 397.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2nc(COc3ccc(CC4SC(=O)NC4=O)cc3)n(C)c2c1.Cl

Standard InChI:  InChI=1S/C20H19N3O4S.ClH/c1-23-16-10-14(26-2)7-8-15(16)21-18(23)11-27-13-5-3-12(4-6-13)9-17-19(24)22-20(25)28-17;/h3-8,10,17H,9,11H2,1-2H3,(H,22,24,25);1H

Standard InChI Key:  LKKAMJRUPIIUTC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    2.3257    1.9113    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.0983   -0.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0971   -1.1356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3870   -1.5485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3852    0.1122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6673   -0.3047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6638   -1.1356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8724   -1.3878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3904   -0.7126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8812   -0.0433    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8087    0.1043    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8085    0.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6315    0.7488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5654   -0.7078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1488   -1.4197    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6821   -1.4149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0967   -2.1265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9209   -2.1220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3300   -1.4046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9088   -0.6902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -0.6983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1549   -1.3986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5725   -2.1100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2451   -2.8648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8622   -3.4124    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5736   -2.9948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3961   -2.1892    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.3297   -3.3248    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4396   -3.0432    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  7  2  0
  6  5  2  0
  5  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  6  1  0
  2 11  1  0
 11 12  1  0
 10 13  1  0
  9 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 23  1  0
 26 28  2  0
 24 29  2  0
M  END

Associated Targets(non-human)

Rhesus monkey (3147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 397.46Molecular Weight (Monoisotopic): 397.1096AlogP: 3.06#Rotatable Bonds: 6
Polar Surface Area: 82.45Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 6.62CX Basic pKa: 4.66CX LogP: 2.83CX LogD: 2.12
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -0.82

References

1. Uchiyama M, Iwabuchi H, Tsuruta F, Abe K, Takahashi M, Koda H, Oguchi M, Okazaki O, Izumi T..  (2011)  Pharmacokinetics, metabolism, and disposition of rivoglitazone, a novel peroxisome proliferator-activated receptor γ agonist, in rats and monkeys.,  39  (4): [PMID:21177486] [10.1124/dmd.110.036194]
2. Uchiyama M, Koda H, Fischer T, Mueller J, Yamamura N, Oguchi M, Iwabuchi H, Okazaki O, Izumi T..  (2011)  In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor γ agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytes.,  39  (7): [PMID:21511943] [10.1124/dmd.111.038729]

Source